Diagnamed Holdings Corp.
DMED
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -47.17% | -43.90% | -12.98% | -14.43% | 13.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.01% | -43.18% | -38.37% | -41.91% | -27.34% |
| Operating Income | 37.01% | 43.18% | 38.37% | 41.91% | 27.34% |
| Income Before Tax | 25.39% | 61.16% | 52.73% | 59.31% | 34.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.39% | 61.16% | 52.73% | 59.31% | 34.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.39% | 61.16% | 52.73% | 59.31% | 34.35% |
| EBIT | 37.01% | 43.18% | 38.37% | 41.91% | 27.34% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 25.30% | 61.98% | 54.84% | 72.73% | 56.54% |
| Normalized Basic EPS | 30.51% | 43.84% | 38.96% | 63.41% | 50.00% |
| EPS Diluted | 25.30% | 61.98% | 54.84% | 72.73% | 56.54% |
| Normalized Diluted EPS | 30.51% | 43.84% | 38.96% | 63.41% | 50.00% |
| Average Basic Shares Outstanding | 1.37% | 2.38% | 3.66% | 24.02% | 23.34% |
| Average Diluted Shares Outstanding | 1.37% | 2.38% | 3.66% | 24.02% | 23.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
